As hepatitis C diagnosis and treatment expand, awareness of hepatitis C drug resistance increases

background

As hepatitis C diagnosis and treatment continue to expand toward global elimination, we have a unique opportunity to address the potential emergence of drug-resistant hepatitis C by maximizing population-level outcomes and prevention and addressing the potential emergence of drug-resistant hepatitis C. Optimizing hepatitis C treatment. This webinar will present an overview of current knowledge on hepatitis C drug resistance in low- and middle-income countries and describe WHO’s comprehensive global actions linking viral hepatitis, HIV and sexually transmitted drug resistance Plan to prevent, monitor and respond to possible hepatitis C drug-resistant planned infections.

Target

1. To provide an overview of current knowledge, research gaps and public health implications related to hepatitis C drug resistance in low- and middle-income countries.
2. Advocate and raise awareness as part of a comprehensive response to viral hepatitis drug resistance.
3. To outline the development and key aspects of an evolving comprehensive global action plan to prevent, monitor and respond to drug resistance in HIV, viral hepatitis and sexually transmitted infections.

date:

Wednesday, November 22, 2023, 13:00-14:30 CET.

language:

The webinar will be held in English.

Register here